Influenza Virus Vaccine for the 2016-2017 Season

Cumulative 2016/2017 Season Lot Release Status (Updated 8/24/2016)

Flu vaccine lots that have been released by FDA and are available for distribution by the manufacturers. For information on flu vaccine distribution schedules, please contact the manufacturers directly.

Manufacturer	Total Number of Lots Released by FDA
Afluria - Seqirus Pty. Ltd.	41
Fluad - Seqirus, Inc.	6
Fluarix Quadrivalent - GlaxoSmithKline Biologicals	42
Flublok - Protein Sciences Corporation	3
Flucelvax Quadrivalent - Seqirus, Inc.	14
FluLaval Quadrivalent - ID Biomedical Corporation of Quebec	11
FluMist Quadrivalent - MedImmune, LLC	6
Fluvirin - Seqirus Vaccines Limited	21
Fluzone High Dose - Sanofi Pasteur, Inc.	14
Fluzone Quadrivalent - Sanofi Pasteur, Inc.	35

FDA's Vaccines and Related Biological Products Advisory Committee (VRBPAC) met in Silver Spring, Maryland, on March 4, 2016, to select the influenza viruses for the composition of the influenza vaccine for the 2016-2017 U.S. influenza season. During this meeting, the advisory committee reviewed and evaluated the surveillance data related to epidemiology and antigenic characteristics of recent influenza isolates, serological responses to 2015-2016 vaccines, and the availability of candidate strains and reagents.

The committee recommended that the trivalent formulation influenza vaccines for the U.S. 2016-2017 influenza season contain the following: